Cite
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
MLA
Pulikkan, John Anto, et al. “Thrombopoietin/MPL Participates in Initiating and Maintaining RUNX1-ETO Acute Myeloid Leukemia via PI3K/AKT Signaling.” Blood, vol. 120, no. 4, July 2012, pp. 868–79. EBSCOhost, https://doi.org/10.1182/blood-2012-03-414649.
APA
Pulikkan, J. A., Madera, D., Xue, L., Bradley, P., Landrette, S. F., Kuo, Y.-H., Abbas, S., Zhu, L. J., Valk, P., & Castilla, L. H. (2012). Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling. Blood, 120(4), 868–879. https://doi.org/10.1182/blood-2012-03-414649
Chicago
Pulikkan, John Anto, Dmitri Madera, Liting Xue, Paul Bradley, Sean Francis Landrette, Ya-Huei Kuo, Saman Abbas, Lihua Julie Zhu, Peter Valk, and Lucio Hernán Castilla. 2012. “Thrombopoietin/MPL Participates in Initiating and Maintaining RUNX1-ETO Acute Myeloid Leukemia via PI3K/AKT Signaling.” Blood 120 (4): 868–79. doi:10.1182/blood-2012-03-414649.